Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation
Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation
复制标题
贝沙罗汀联合拉帕替尼治疗库欣病:基于药物重新定位和实验证实的证据
DOI:
10.1038/s41392-020-00284-7
复制
发表时间:
2020-08
影响因子:
39.3
通讯作者:
Guanhua Du
中科院分区:
文献类型:
--
作者:
Haoying Yu;Shuyue Ren;Jingrong Wang;Tingting Lv;Lan Sun;Guanhua Du
Dear Editor, Cushing’s disease (CD) is a rare disease manifested as Cushing’s syndrome caused by adrenocorticotropic hormone (ACTH) consistently over-secreted by adrenocorticotropic adenomas, followed by stimulation of the adrenal gland to secrete conside
登录
查看更多内容
DOI:
10.1172/jci11098
发表时间:
2001-10
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
M. Páez-Pereda;Damián Kovalovsky;Ursula Hopfner;M. Theodoropoulou;U. Pagotto;Eberhard Uhl;Marco Losa-M
通讯作者:
M. Páez-Pereda;Damián Kovalovsky;Ursula Hopfner;M. Theodoropoulou;U. Pagotto;Eberhard Uhl;Marco Losa-M
DOI:
10.1210/jcem.81.7.8675592
发表时间:
1996-07
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
N. Sonino;Maria Zielezny;G. A. Fava;Francesco Fallo;Marco Boscaro
通讯作者:
N. Sonino;Maria Zielezny;G. A. Fava;Francesco Fallo;Marco Boscaro
影响因子:
4.1
作者:
Lau, Darryl;Rutledge, Caleb;Aghi, Manish K.
通讯作者:
Aghi, Manish K.
影响因子:
2
作者:
A. Uruno;Akiko Saito-hakoda;A. Yokoyama;N. Kogure;K. Matsuda;R. Parvin;K. Shimizu;I. Sato;M. Kudo;T. Yoshikawa;H. Kagechika;Y. Iwasaki;S. Ito;A. Sugawara
通讯作者:
A. Uruno;Akiko Saito-hakoda;A. Yokoyama;N. Kogure;K. Matsuda;R. Parvin;K. Shimizu;I. Sato;M. Kudo;T. Yoshikawa;H. Kagechika;Y. Iwasaki;S. Ito;A. Sugawara
影响因子:
5.8
作者:
Sonino, N;Zielezny, M;Boscaro, M
通讯作者:
Boscaro, M